Articles

Qiming Star | Immune-Mediated Disease Leader Attovia Therapeutics Debuts on Nasdaq | Bilingual

Focused on developing next-generation biotherapeutics for immune-mediated diseases with significant unmet clinical needs.

MaHui | Sand.ai Releases World's First 100B+ Open-Source MoE Video Model

Going forward, we will continue scaling up model and data size, and explore video generation at longer durations.

"NewPro" Raises Tens of Millions of RMB in Pre-A Round; Linear Capital Led Angel Round | Linear Portfolio

Focused on the bio-manufacturing of scarce functional proteins found in nature.

Qwen 3.8 Upgrades to Pure "Digital Laborer" Model

Don't be Wang Feng next time.

BlueRun Ventures' Jui Chan on Data, Value, and Long-Term Judgment: What Will Actually Survive the AI Hype?

Reflection and Perseverance in Practice

"What Makes You Love an Industry for 15 Years?" | A Conversation with Wang Tianfan: I Want to Invest in True Joy, the Purest Vision, and the Brilliance of Human Nature [Highway Podcast]

Autumn's First Whispers, Wanwu's Harvest | Vital Monthly

Counselor Vitality

MaHui Journal July Issue | World's First 3-Trillion-Parameter Open-Source Model Released

[![](https://mmbiz.qpic.cn/sz_mmbiz_png/dHiadeLibwQKPjnAfRUSpLZzs9RfHKfDNBib49ODoyVz0gB4SnOBAuvR8MiaXr6lJGWquoje2mefnZLqm8OSCYahIugXiaLNqngiaHvo8R2VB6

14.9 Grams of Obsession and Six "Anti-Consensus" Views

"First, a pair of glasses"

Meituan's LLM Is as Free as Its Delivery Service

Bullish on Meituan building world models